Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0JF6O
|
|||
Former ID |
DIB014145
|
|||
Drug Name |
Eltenac
|
|||
Synonyms |
BY-820; B-788-20
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Arthritis [ICD-11: FA20] | Discontinued in Phase 1 | [1] | |
Company |
ALTANA Pharma AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H9Cl2NO2S
|
|||
Canonical SMILES |
C1=CC(=C(C(=C1)Cl)NC2=CSC=C2CC(=O)O)Cl
|
|||
InChI |
1S/C12H9Cl2NO2S/c13-8-2-1-3-9(14)12(8)15-10-6-18-5-7(10)4-11(16)17/h1-3,5-6,15H,4H2,(H,16,17)
|
|||
InChIKey |
AELILMBZWCGOSB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 72895-88-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin G/H synthase (COX) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003785) | |||
REF 2 | Effect of eltenac in horses with induced endotoxaemia. Equine Vet J Suppl. 2000 Jun;(32):26-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.